Viewing Study NCT06651593


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-01-01 @ 7:19 AM
Study NCT ID: NCT06651593
Status: RECRUITING
Last Update Posted: 2025-08-15
First Post: 2024-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module